Bioregenx (BRGX) Shares Outstanding (Diluted Average) (2021 - 2026)

Bioregenx's Shares Outstanding (Diluted Average) history runs 6 years deep, the most recent figure standing at $969.2 million for Q1 2026.

• In Q1 2026, Shares Outstanding (Diluted Average) rose 1.27% year-over-year to $969.2 million; the TTM figure through Mar 2026 stood at $969.2 million (up 1.27% YoY), while the FY2025 annual figure was $959.7 million, up 5.19% from the prior year.
• Shares Outstanding (Diluted Average) was $969.2 million for Q1 2026 at Bioregenx, up from $959.7 million in the prior quarter.
• In the past five years, Shares Outstanding (Diluted Average) ranged from a high of $969.2 million in Q1 2026 to a low of $269.7 million in Q1 2022.
• Historically, Shares Outstanding (Diluted Average) has averaged $711.1 million across 5 years, with a median of $767.6 million in 2024.
• The sharpest annual moves came in 2022 and 2023: Shares Outstanding (Diluted Average) changed 0.0% in 2022, then jumped 182.49% in 2023.
• A 5-year view of Shares Outstanding (Diluted Average) shows it stood at $269.7 million in 2022, then jumped by 137.18% to $639.8 million in 2023, then surged by 42.61% to $912.4 million in 2024, then climbed by 5.19% to $959.7 million in 2025, then gained by 0.99% to $969.2 million in 2026.
• The last three Shares Outstanding (Diluted Average) figures came in at $969.2 million (Q1 2026), $959.7 million (Q4 2025), and $959.1 million (Q3 2025), per Business Quant data.